Propylisopropyltryptamine

PiPT, also known as N-propyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family. It reportedly produces psychedelic effects that resemble those of other related dialkyl tryptamine derivatives,^[1] although PiPT is reportedly relatively weak and short-lasting. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.^[2]

Propylisopropyltryptamine

Clinical data
Other names	N-Propyl-N-isopropyltryptamine
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	none
Identifiers
IUPAC name [2-(1H-indol-3-yl)ethyl]-N-propyl-N-isopropylamine
CAS Number	1354632-00-0 N
PubChem CID	57464898
ChemSpider	21106369 Y
UNII	Q2Y9D5Q4T4
CompTox Dashboard (EPA)	DTXSID20726699
Chemical and physical data
Formula	C16H24N2
Molar mass	244.382 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)N(CCC)CCc2c[nH]c1ccccc12
InChI InChI=1S/C16H24N2/c1-4-10-18(13(2)3)11-9-14-12-17-16-8-6-5-7-15(14)16/h5-8,12-13,17H,4,9-11H2,1-3H3 Y Key:OFXPLOPRCQJJFP-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Interactions

See also: Psychedelic drug § Interactions, and Trip killer § Serotonergic psychedelic antidotes

Chemistry

PiPT is short for N-propyl-N-isopropyl-tryptamine. PiPT is a tryptamine, which all belong to a larger family of compounds known as indolethylamines. PiPT is closely related to the compounds DPT and DiPT.

Society and culture

Legal status

United States

PiPT is unscheduled and uncontrolled in the United States.^{[citation needed]}

See also

• Substituted tryptamine